Cipher Pharmaceuticals Inc
TSX:CPH
Cipher Pharmaceuticals Inc
Goodwill
Cipher Pharmaceuticals Inc
Goodwill Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Goodwill | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
Goodwill
$17.4m
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
10%
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Goodwill
$11.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Goodwill
CA$124.2m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Goodwill
$65.4m
|
CAGR 3-Years
301%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Goodwill
$19.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Goodwill
CA$92.2m
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Cipher Pharmaceuticals Inc
Glance View
Cipher Pharmaceuticals, Inc. engages as a specialty pharmaceutical company, which have diversified portfolio of commercial and early to late-stage products. The company is headquartered in Oakville, Ontario. The company went IPO on 2004-02-25. The firm acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products directly in Canada and indirectly through partners in the United States, Canada and South America. Its Dermatology products include Actikerall, Epuris, Ozanex, and Vaniqa. Its Hospital Acute Care products are Aggrastat and Brinavess. The Company’s Out-Licensed Products include Absorica, ConZip, Durela, and Lipofen. The company is focused on three strategy that includes acquisitions, in-licensing, and selective investments in drug development to assemble a portfolio of prescription products that serve unmet medical needs. The firm's subsidiaries include Cipher US Holdings Inc., Cipher US Holdco LLC and Cipher Pharmaceuticals US LLC.
See Also
What is Cipher Pharmaceuticals Inc's Goodwill?
Goodwill
17.4m
USD
Based on the financial report for Sep 30, 2025, Cipher Pharmaceuticals Inc's Goodwill amounts to 17.4m USD.
What is Cipher Pharmaceuticals Inc's Goodwill growth rate?
Goodwill CAGR 10Y
10%
Over the last year, the Goodwill growth was 9%. The average annual Goodwill growth rates for Cipher Pharmaceuticals Inc have been 4% over the past three years , 2% over the past five years , and 10% over the past ten years .
